Chronic Idiopathic Constipation (CIC) Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Chronic Idiopathic Constipation (CIC) Treatment Market : By Drug Class (Emollients, Laxatives, Bulk-forming agents, Chloride channel activators, Osmotic products, Others), By Route of Administration (Oral, Parenteral), By Distribution Mode (Prescription mode, Over-the-counter drugs), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies, Drug Stores) and Geography 

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global Chronic Idiopathic Constipation (CIC) Treatment Market size was estimated at USD 8.2Bn in 2021, growing at a CAGR of 7.2% during the forecast period 2021-2027. Chronic idiopathic constipation is a functional gastrointestinal disorder which leads to difficulty in defecating. It is a more chronic or severe condition and the symptoms of the disease include bloating, abdominal discomfort, hard stool, incomplete evacuation, gastric pain, and strain during the bowel movement. It is an idiopathic condition due to the causes of the disease are unclear, however, it may cause due to psychological, neurological, and psychosomatic conditions. Chronic idiopathic constipation is majorly caused in the adults or geriatric people. Diagnosis of CIC is difficult due to the lack of physiological causes and physicians look for symptoms like weight, blood in stool, and low blood count among others. The chronic idiopathic constipation Treatment market is growing at a significant CAGR owing to recent product approvals and competitors focus on the development of newer drugs for CIC treatment. Moreover, increase in the prevalence of chronic idiopathic constipation cases also expected to propel the market revenue over the forecast period. Acquisitions and mergers, product approvals, and product launchings are the key strategies adopted by the companies for increasing their revenue share in the market. For instance, In January 2017, FDA approved Tulane manufactured by Synergy Pharmaceuticals used in the treatment of chronic idiopathic constipation.


Chronic Idiopathic Constipation (CIC) Treatment Market

MARKET SUMMARY
-
7.2% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 7.2%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Chronic Idiopathic Constipation Treatment Market

  • In September 2017, Astellas Pharma, Inc. submitted the Supplemental new drug application for Linaclotide for patients with chronic idiopathic constipation in Japan
  • In January 2017, FDA approved the Linzess for the treatment of chronic idiopathic constipation manufactured by Allergan Plc. and Ironwood Pharmaceuticals, Inc.
Market Key Players
  • GlaxoSmithKline Plc. (U.K.)
  • Bayer AG (Germany)
  • Allergan Plc. (Ireland)
  • Ironwood Pharmaceuticals, Inc. (U.S.)
  • Astellas Pharma, Inc. (Japan)
Drivers And Restraints

Chronic Idiopathic Constipation (CIC) Treatment Market

Increase in the prevalence of chronic idiopathic constipation due to change in lifestyle and food habits, rise in awareness about the CIC treatment, increase in the demand for CIC drugs, and availability of the over-the-counter CIC drugs in the market are driving the chronic idiopathic constipation treatment market. Moreover, various pipeline drugs for the CIC treatment and frequent product approvals from various drug regulatory bodies are propelling the chronic idiopathic constipation treatment market. However, lack of physiological symptoms for the disease and less number of drugs available for CIC treatment are the factors anticipated to hinder the growth of Chronic Idiopathic Constipation Treatment Market.


North-America got significant share

Chronic Idiopathic Constipation (CIC) Treatment Market

Geographically, Chronic Idiopathic Constipation Treatment Market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America has a significant share in market owing to increase in the prevalence if CIC disease (according to National Institute of Health, approximately 63 Mn people affected with CIC in U.S.), change in lifestyle, recent FDA approvals for CIC treatment drugs, an increase in healthcare expenditure. In Europe, increase in ageing population, rise in R&D activities for CIC treatments, availability of over-the-counter CIC drugs, an increase in per capita income might bolster the market. However, Asia Pacific exhibiting lucrative growth owing to the rise in geriatric population, an increase in adoption of CIC treatments.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, and forecast from 2021-2027
  • The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments, and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

 

Segmentation

Chronic Idiopathic Constipation (CIC) Treatment Market


Location

GEOGRAPHY


Report

Table Of Content

  1. Table of Content
  2. Executive Summary
  3. Global Chronic Idiopathic Constipation (CIC) Treatment Market Introduction
    • Global Chronic Idiopathic Constipation (CIC) Treatment Market – Taxonomy
    • Global Chronic Idiopathic Constipation (CIC) Treatment Market –Definitions
      • Drug Class
      • Route of Administration
      • Distribution Mode
      • Distribution Channel
  1. Global Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Chronic Idiopathic Constipation (CIC) Treatment Market Dynamic Factors – Impact Analysis
    • Global Chronic Idiopathic Constipation (CIC) Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Chronic Idiopathic Constipation (CIC) Treatment Market Analysis,2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Chronic Idiopathic Constipation (CIC) Treatment Market, By Drug Class, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Emollients
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Laxatives
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Bulk-forming agents
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Chloride channel activators
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Osmotic products
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Chronic Idiopathic Constipation (CIC) Treatment Market Forecast, By Route of Administration,2015 – 2019 and Forecast, 2020 – 2026
    • Oral
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Parenteral
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Chronic Idiopathic Constipation (CIC) Treatment Market Forecast, By Distribution Mode, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Prescription mode
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Over-the-counter drugs
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Chronic Idiopathic Constipation (CIC) Treatment Market Forecast, By Distribution Channel, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Hospital pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Drug Stores
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Chronic Idiopathic Constipation (CIC) Treatment Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Region, 2020 – 2026
  2. North America Chronic Idiopathic Constipation (CIC) Treatment MarketAnalysis,2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Drug Class Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Emollients
      • Laxatives
      • Bulk-forming agents
      • Chloride channel activators
      • Osmotic products
      • Others
    • Route of Administration Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Mode Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription mode
      • Over-the-counter drugs
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
      • Drug Stores
    • Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Country, 2020 – 2026
    • North America Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics – Trends
  3. Europe Chronic Idiopathic Constipation (CIC) Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Drug Class Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Emollients
      • Laxatives
      • Bulk-forming agents
      • Chloride channel activators
      • Osmotic products
      • Others
    • Route of Administration Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Mode Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription mode
      • Over-the-counter drugs
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
      • Drug Stores
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Country, 2020 – 2026
    • Europe Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics – Trends
  4. Asia-Pacific Chronic Idiopathic Constipation (CIC) Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Drug Class Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Emollients
      • Laxatives
      • Bulk-forming agents
      • Chloride channel activators
      • Osmotic products
      • Others
    • Route of Administration Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Mode Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription mode
      • Over-the-counter drugs
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
      • Drug Stores
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Country, 2020 – 2026
    • Asia-Pacific Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics – Trends
  5. Latin America Chronic Idiopathic Constipation (CIC) Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Drug Class Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Emollients
      • Laxatives
      • Bulk-forming agents
      • Chloride channel activators
      • Osmotic products
      • Others
    • Route of Administration Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Mode Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription mode
      • Over-the-counter drugs
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
      • Drug Stores
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Country, 2020 – 2026
    • Latin America Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics – Trends
  6. Middle East and Africa Chronic Idiopathic Constipation (CIC) Treatment Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026(Revenue, USD Mn)
    • Drug Class Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Emollients
      • Laxatives
      • Bulk-forming agents
      • Chloride channel activators
      • Osmotic products
      • Others
    • Route of Administration Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Oral
      • Parenteral
    • Distribution Mode Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Prescription mode
      • Over-the-counter drugs
    • Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital pharmacies
      • Retail pharmacies
      • Online pharmacies
      • Drug Stores
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Chronic Idiopathic Constipation (CIC) Treatment Market – Opportunity Analysis Index, By Drug Class, By Route of Administration, By Distribution Mode, By Distribution Channel, and Country, 2020 – 2026
    • MEA Chronic Idiopathic Constipation (CIC) Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug Class& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • GlaxoSmithKline Plc. (U.K.)
      • Bayer AG (Germany)
      • Allergan Plc. (Ireland)
      • Ironwood Pharmaceuticals, Inc. (U.S.)
      • Astellas Pharma, Inc. (Japan)
      • synergy pharmaceuticals, Inc. (U.S.)
      • Sanofi S.A. (France)
      • Pfizer, Inc. (U.S.)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

  1. Disclaimer: The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

Report

Company Profile

  • GlaxoSmithKline Plc. (U.K.)
  • Bayer AG (Germany)
  • Allergan Plc. (Ireland)
  • Ironwood Pharmaceuticals, Inc. (U.S.)
  • Astellas Pharma, Inc. (Japan)
  • synergy pharmaceuticals, Inc. (U.S.)
  • Sanofi S.A. (France)
  • Pfizer, Inc. (U.S.)

Description

The global Chronic Idiopathic Constipation (CIC) Treatment Market size was estimated at USD 8.2Bn in 2021, growing at a CAGR of 7.2% during the forecast period 2021-2027. Chronic idiopathic constipation is a functional gastrointestinal disorder which leads to difficulty in defecating. It is a more chronic or severe condition and the symptoms of the disease include bloating, abdominal discomfort, hard stool, incomplete evacuation, gastric pain, and strain during the bowel movement. It is an idiopathic condition due to the causes of the disease are unclear, however, it may cause due to psychological, neurological, and psychosomatic conditions. Chronic idiopathic constipation is majorly caused in the adults or geriatric people. Diagnosis of CIC is difficult due to the lack of physiological causes and physicians look for symptoms like weight, blood in stool, and low blood count among others. The chronic idiopathic constipation Treatment market is growing at a significant CAGR owing to recent product approvals and competitors focus on the development of newer drugs for CIC treatment. Moreover, increase in the prevalence of chronic idiopathic constipation cases also expected to propel the market revenue over the forecast period. Acquisitions and mergers, product approvals, and product launchings are the key strategies adopted by the companies for increasing their revenue share in the market. For instance, In January 2017, FDA approved Tulane manufactured by Synergy Pharmaceuticals used in the treatment of chronic idiopathic constipation.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX